Trial Profile
A 3-Parts, randomized, double-blind, placebo-controlled, single and multiple ascending-dose study evaluating the safety, pharmacokinetics and tolerability of delafloxacin in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Delafloxacin (Primary)
- Indications Skin and soft tissue infections
- Focus Adverse reactions; Pharmacokinetics
- 27 Nov 2015 New trial record
- 12 Nov 2015 Results published in the Clinical Therapeutics